Welcome to our dedicated page for Broadridge Finl Solutions SEC filings (Ticker: BR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Broadridge Financial Solutions, Inc. (NYSE: BR), a global Fintech and technology company serving the financial services industry. Broadridge’s filings offer detailed insight into its technology and operations platforms that power investing, governance, and communications, support post-trade processing and asset servicing, and underpin the daily average trading of more than $15 trillion in securities globally.
Through Broadridge’s annual reports on Form 10-K and quarterly reports on Form 10-Q, investors can review discussions of its business model, segment performance, risk factors, and financial condition. The company’s definitive proxy statement on Schedule 14A describes corporate governance practices, Board composition, executive compensation, and matters submitted to stockholder vote, including the election of directors, advisory votes on executive pay, and ratification of independent auditors.
Broadridge also files frequent current reports on Form 8-K that disclose material events such as dividend declarations, earnings releases, financing arrangements like term credit agreements, investor presentations, and results of stockholder meetings. These filings can include information on the company’s capital allocation approach, including recurring cash dividends, as well as updates on its growth strategy and operational priorities.
In addition, investors can monitor Forms 3, 4, and 5 for information on insider share ownership and changes in holdings by directors and officers, and Schedule 13 filings for significant beneficial ownership by large shareholders, where applicable. Together, these documents provide a regulatory record of Broadridge’s activities as a public company listed on the New York Stock Exchange.
On Stock Titan, Broadridge’s SEC filings are supplemented with AI-powered summaries that highlight key points from lengthy documents, helping users quickly understand major themes in 10-K and 10-Q reports, the implications of 8-K disclosures, and notable aspects of proxy materials. Real-time updates from EDGAR, combined with simplified explanations, support investors, analysts, and researchers who want to follow BR’s governance, risk disclosures, capital structure, and corporate actions in a structured and accessible way.
Broadridge Financial Solutions, Inc. reported an insider equity award for one of its directors. On 12/10/2025 the director received 149 shares of Broadridge common stock in the form of Deferred Stock Units under the company’s 2018 Omnibus Award Plan, tied to the deferral of cash compensation under the Director Deferred Compensation Program.
The Deferred Stock Units vest in full immediately upon grant and will be settled in shares of Broadridge common stock when the director separates from service with the company. Following this grant, the director beneficially owns 9,136 shares, held directly.
Broadridge Financial Solutions reported an equity compensation transaction for one of its directors. On 12/10/2025, the director received 299 shares of common stock in the form of Deferred Stock Units under Broadridge's 2018 Omnibus Award Plan, linked to the deferral of cash compensation under the Director Deferred Compensation Program. These units vest in full upon grant and will be settled in shares of Broadridge common stock when the director separates from service. After this grant, the director beneficially owns 4,842 shares of Broadridge common stock held directly.
Broadridge Financial Solutions, Inc. reported a routine equity grant to one of its directors. On 12/10/2025, a director received 138 shares of Broadridge common stock in the form of Deferred Stock Units under the company’s 2018 Omnibus Award Plan, tied to the deferral of cash compensation under the Director Deferred Compensation Program. These units vest in full upon grant and are designed to settle in an equal number of Broadridge common shares when the director separates from service with the company. Following this award, the director beneficially owns 8,481 shares of Broadridge common stock, held directly.
Broadridge Financial Solutions director reports new equity grant. A company director received 160 shares of Broadridge common stock on December 10, 2025 in the form of Deferred Stock Units under the 2018 Omnibus Award Plan. These units vest immediately and are scheduled to be settled in Broadridge common shares when the director leaves board service. Following this grant, the director beneficially owns a total of 31,940.102 shares of Broadridge common stock held directly.
Broadridge Financial Solutions, Inc. reported an equity compensation transaction by a director. On 12/10/2025, the director received 138 shares of Broadridge common stock in the form of Deferred Stock Units under the company’s 2018 Omnibus Award Plan, linked to the deferral of cash compensation under the Director Deferred Compensation Program. These units vest in full upon grant and will be settled in shares of Broadridge common stock when the director separates from service. Following this grant, the director beneficially owns 16,654 shares of Broadridge common stock in direct ownership.
Broadridge Financial Solutions CEO reports charitable stock gift
The CEO of Broadridge Financial Solutions reported a disposition of 5,709 shares of common stock on 12/05/2025, coded as a bona fide charitable gift at a price of $0.0000. After this transaction, the reporting person beneficially owns 137,576.0271 shares of Broadridge common stock in direct ownership. The filing indicates this was a voluntary transfer for charitable purposes rather than an open-market sale.
Broadridge Financial Solutions, Inc. insider stock activity: A corporate vice president reported multiple option exercises and share sales in Broadridge Financial Solutions, Inc. common stock. On 12/03/2025, the officer exercised stock options for 6,000 shares at an exercise price of $148.07 and 4,163 shares at an exercise price of $93.88. The same day, the officer sold 1,150, 3,516 and 5,548 shares of common stock at a weighted average price of $229.2557 per share, with the actual sale prices ranging from $228.89 to $229.71. Following these transactions, the officer directly beneficially owns 6,026 shares of Broadridge common stock and 8,548 stock options.
An affiliate of the issuer filed a Form 144 notice to sell 10,214 shares of common stock through Morgan Stanley Smith Barney LLC on or about 12/03/2025 on the NYSE. The filing lists an aggregate market value of $2,341,617.72 for the planned sale and notes that 116,727,559 shares of this class were outstanding.
The securities to be sold were acquired through restricted stock vesting and stock option exercises under registered plans. These include 1,150 shares from restricted stock vesting on 11/11/2024 and option exercises for 3,516 and 5,548 shares on 12/03/2025, with the option exercises paid in cash. The signer represents that they are not aware of undisclosed material adverse information about the issuer’s operations.
BR reported a planned sale of restricted stock under Rule 144. A holder intends to sell 3984 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of 900384. The shares were acquired on 04/01/2025 through restricted stock vesting under a registered plan from the issuer. The notice lists 116727559 shares of the issuer’s common stock outstanding, providing context for the relative size of this planned sale.
Broadridge Financial Solutions (BR) reported an insider stock sale by a company officer who serves as President. On 11/18/2025, the officer sold 3,984 shares of Broadridge common stock in an open market transaction coded "S" at a price of $226 per share. After this transaction, the officer continued to beneficially own 44,828.521 shares of Broadridge common stock, held in direct ownership. This filing reflects a routine Form 4 disclosure of insider trading activity by a single reporting person.